News
Important Only
Soccer-Man United end miserable month with 2-0 home loss to Newcastle
By Lori EwingMANCHESTER, England, Dec 30 (Reuters) - Newcastle United easily overcame Manchester United 2-0 in the Premier League on Monday thanks to early headed goals from Alexander Isak and Joelinton at Old Trafford.With five losses in their last six league games, Manchester United languish 14th ...Reuters
Mon, Dec 30
BRIEF-Pulsar Helium Arranging A Brokered Private Placement Of Up To 19.74 Mln Common Shares Of Co AT$0.38 Per Share
Dec 30 (Reuters) - PULSAR HELIUM INC: ARRANGING A BROKERED PRIVATE PLACEMENT OF UP TO 19.74 MILLION COMMON SHARES OF CO AT$0.38 PER SHARESource text: [ID:] ((Reuters.Briefs@thomsonreuters.com;))Reuters
Mon, Dec 30
BRIEF-Payoneer Global- Board Plans To Amend Bylaws To Replace Plurality Voting Standard With Majority Voting For Uncontested Director Elections
Dec 30 (Reuters) - Payoneer Global Inc PAYO.O:PAYONEER GLOBAL- BOARD PLANS TO AMEND BYLAWS TO REPLACE PLURALITY VOTING STANDARD WITH MAJORITY VOTING FOR UNCONTESTED DIRECTOR ELECTIONSSource text: [ID:n0000950103-24-018486]Further company coverage: PAYO.O ((Reuters.Briefs@thomsonreuters.com;))Reuters
Mon, Dec 30
BRIEF-Adc Therapeutics Announces Completion Of Enrollment Of Phase 3 Confirmatory Clinical Trial Of Zynlonta In Combination With Rituximab In 2L+ Diffuse Large B-Cell Lymphoma
Dec 30 (Reuters) - ADC Therapeutics SA ADCT.N:ADC THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT OF PHASE 3 CONFIRMATORY CLINICAL TRIAL OF ZYNLONTA® IN COMBINATION WITH RITUXIMAB IN 2L+ DIFFUSE LARGE B-CELL LYMPHOMASource text: ID:nPn4FzrXCaFurther company coverage: ADCT.N ((Reuters.Briefs@thomsonr...Reuters
Mon, Dec 30
BRIEF-Inotiv Completes Equity Offering For Net Proceeds Of Approximately $3.6 Mln
Dec 30 (Reuters) - Inotiv Inc NOTV.O:INOTIV, INC. COMPLETES EQUITY OFFERING FOR NET PROCEEDS OF APPROXIMATELY $3.6 MILLIONSource text: ID:nGNX3LLT8rFurther company coverage: NOTV.O ((Reuters.Briefs@thomsonreuters.com;))Reuters
Mon, Dec 30
UPDATE 1-North Korea's Kim vows to further solidify Russia ties in letter to Putin
Adds details, background in paragraphs 2-5 SEOUL, Dec 31 (Reuters) - North Korean leader Kim Jong Un pledged to solidify the country's comprehensive strategic partnership with Russia in his letter to President Vladimir Putin on Monday, state media KCNA reported on Tuesday. In the message, Kim sen...Reuters
Mon, Dec 30
UPDATE 1-US files complaint against fintech app Dave and its CEO
Adds details about complaint, company reaction to allegations in paragraphs 4-6By Kanishka Singh WASHINGTON, Dec 30 (Reuters) - The U.S. Justice Department filed a complaint and announced a civil enforcement action on Monday against financial technology company Dave Inc DAVE.O and its CEO Jason W...Reuters
Mon, Dec 30
UPDATE 1-One overnight repo rate measure rises as year-end approaches
Other repo rates showing more benign levelsSOFR was at 4.46% last FridayBanks started cleaning up balance sheets last week, analyst saysAdds analyst comment in paragraph 7, detailsBy Gertrude Chavez-DreyfussNEW YORK, Dec 30 (Reuters) - One measure of the U.S. overnight repurchase rate rose on Monday...Reuters
Mon, Dec 30
UPDATE 3-US Treasury says Chinese hackers stole documents in 'major incident'
Adds background from BeyondTrust statement and attempt to reach Chinese Embassy in paragraphs 6 and 7.Dec 30 (Reuters) - Chinese state-sponsored hackers broke into the U.S. Treasury Department earlier this month and stole documents from its workstations, according to a letter to lawmakers that was p...Reuters
Mon, Dec 30
BRIEF-Siriuspoint Announces Full Repurchase Of Cm Bermuda Shares
Dec 30 (Reuters) - Siriuspoint Ltd SPNT.N:SIRIUSPOINT ANNOUNCES FULL REPURCHASE OF CM BERMUDA SHARESSIRIUSPOINT LTD: PROPOSED DEAL FOR AGGREGATE PURCHASE PRICE OF $733 MILLIONSIRIUSPOINT LTD: ENTERED INTO AGREEMENT TO REPURCHASE ALL SIRIUSPOINT COMMON SHARES AND WARRANTS HELD BY CM BERMUDA FOR PURC...Reuters
Mon, Dec 30
BRIEF-Verastem Oncology Announces FDA Acceptance And Priority Review Of New Drug Application For Avutometinib In Combination With Defactinib For The Treatment Of Recurrent Kras Mutant Low-Grade Serous Ovarian Cancer
Dec 30 (Reuters) - Verastem Inc VSTM.O:VERASTEM ONCOLOGY ANNOUNCES FDA ACCEPTANCE AND PRIORITY REVIEW OF NEW DRUG APPLICATION FOR AVUTOMETINIB IN COMBINATION WITH DEFACTINIB FOR THE TREATMENT OF RECURRENT KRAS MUTANT LOW-GRADE SEROUS OVARIAN CANCERVERASTEM INC - PDUFA TARGET ACTION DATE SET FOR JUNE...Reuters
Mon, Dec 30
BRIEF-Fibrobiologics Closes Second $5 Mln Tranche Of $25 Mln Financing
Dec 30 (Reuters) - Fibrobiologics Inc FBLG.O:FIBROBIOLOGICS CLOSES SECOND $5 MILLION TRANCHE OF $25 MILLION FINANCINGSource text: ID:nGNX3wQ63zFurther company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))Reuters
Mon, Dec 30
BRIEF-Apcu/Center Parc Credit Union And Affinity Bancshares Announce Mutual Termination Of Purchase Agreement
Dec 30 (Reuters) - APCU/CENTER PARC CREDIT UNION AND AFFINITY BANCSHARES, INC. ANNOUNCE MUTUAL TERMINATION OF PURCHASE AGREEMENTSource text: ID:nBw9HcfYNa ((Reuters.Briefs@thomsonreuters.com;))Reuters
Mon, Dec 30
BRIEF-Comstock Fuels Executes License Agreement With Gresham’S Eastern Ltd
Dec 30 (Reuters) - Comstock Inc LODE.A:COMSTOCK FUELS EXECUTES LICENSE AGREEMENT WITH GRESHAM’S EASTERN LTDCOMSTOCK INC - WILL CONTRIBUTE SITE SPECIFIC TECHNOLOGY RIGHTS IN EXCHANGE FOR A 20% EQUITY STAKE IN EACH BIOLEUM REFINERYSource text: ID:nGNX8qVmhxFurther company coverage: LODE.A ((Reuters.Br...Reuters
Mon, Dec 30
BRIEF-Seneca Foods Units Enter Loan And Security Agreement
Dec 30 (Reuters) - SENECA FOODS CORP - CO, UNITS ENTER LOAN AND SECURITY AGREEMENTSENECA FOODS CORP - LOAN AGREEMENT INCLUDES $450 MILLION REVOLVING CREDIT FACILITYSource text: [ID:n0001437749-24-038531] ((Reuters.Briefs@thomsonreuters.com;))Reuters
Mon, Dec 30
